Life Sciences

Natick biotech firm Pillar Biosciences received premarket approval from the U.S. Food and Drug Administration for its oncoRevea Dx Lung and Colon Cancer Assay, according to a press release Thursday.

Harvard Bioscience, a life science equipment manufacturer based in Holliston, reported a net loss of $410,000 for the company’s second quarter financials in an earnings report released on Thursday.

Framingham’s SCIEX life sciences analytics company announced a partnership with Swiss biopharma group Genedata, marrying hardware and software technology to allow customers to develop drugs more rapidly.

Hologic, a Marlborough based medical technology company specializing in women's health, reported a net income of $268.4 million for the company’s third quarter in an earnings report released on Wednesday.

Massachusetts employers, especially those in skilled trades, often talk about the need to continuously attract, train and retain workers with in-demand skills, and though they are developing COVID-19 vaccines here, Moderna and Pfizer are not immune to the problem.

Boston Scientific reported $172 million in profits during the company’s second quarter, continuing a positive financial trend following a $328-million profit reported in the company’s first quarter.

Cytiva and Pall Corp. announced on Tuesday a plan to invest $1.5 billion dollars over two years to meet what the companies called growing demand for biotechnology solutions.

MBI President and CEO Jon Weaver spoke with WBJ about the company’s history, its current growth, and new programming.

Albany company Curia, a contract research, development and manufacturing company formerly known as AMRI, announced it has entered into an agreement to acquire LakePharma Inc.

The Cryo-EM Core facility at UMass Medical School received $2.8 million from the Massachusetts Life Sciences Center on Thursday to purchase a cryo-electron microscope to support the team’s structural biology research.